Novoheart is a groundbreaking stem cell biotechnology company that has created miniature living human heart pumps for drug discovery. It is the only company in the world that has engineered such prototypes, which can revolutionize drug development, saving both time and money. Novoheart's bio-artificial human heart constructs are made using state-of-the-art and proprietary stem cell and bioengineering approaches, which are utilized by global pharmaceutical and biotech companies for preclinical testing. The company has offices and laboratories in the United States, Canada, and Hong Kong.
Novoheart Holdings Inc.'s ticker is NVH
The company's shares trade on the TSX-V stock exchange
They are based in Irvine, California
There are 11-50 employees working at Novoheart Holdings Inc.
It is http://www.novoheart.com/hk/home
Novoheart Holdings Inc. is in the Healthcare sector
Novoheart Holdings Inc. is in the Biotechnology industry
The following five companies are Novoheart Holdings Inc.'s industry peers: